GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (OTCPK:MSCLF) » Definitions » Other Financing

MSCLF (Satellos Bioscience) Other Financing : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Other Financing?

Satellos Bioscience's Other Financing for the three months ended in Sep. 2024 was $0.00 Mil.

Satellos Bioscience's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Satellos Bioscience Other Financing Historical Data

The historical data trend for Satellos Bioscience's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Other Financing Chart

Satellos Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Financing
- 0.15 - 14.05

Satellos Bioscience Quarterly Data
Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 - - - -

Satellos Bioscience Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Satellos Bioscience Other Financing Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (OTCPK:MSCLF) » Definitions » Other Financing
Comparable Companies
TSX:MDNA TSXV:MIR TSX:ONC TSXV:COV TSX:MBX XCNQ:DTC TSX:SVA XCNQ:ONCO XCNQ:GLAB TSXV:SHRX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
0IT:Germany MSCL:Canada
Address
200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Website
https://www.satellos.com
Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.